Skip to main content

Advertisement

SpringerLink
Log in

Clinical activity of arsenic trioxide in Burkitt-like lymphoma

  • Correspondence
  • Published:
Leukemia Submit manuscript

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Figure 1

References

  1. Magrath, I, Adde, M, Shad, A, Venzon, D, Seibel, N, Gootenberg, J, Neely, J, Arndt, C, Nieder, M, Jaffe, E, Wittes, RA & Horak, ID Adults and children with small non-cleaved-cell lymphoma have a similar excellent outcome when treated with the same chemotherapy regimen. J Clin Oncol, (1996). 14, 925–934.

    Article  CAS  Google Scholar 

  2. Lee, EJ, Petroni, GR, Schiffer, CA, Freter, CE, Johnson, JL, Barcos, M, Frizzera, G, Bloomfield, CD & Peterson, BA Brief-duration high-intensity chemotherapy for patients with small noncleaved-cell lymphoma or FAB L3 acute lymphocytic leukemia: results of Cancer and Leukemia Group B Study 9251. J Clin Oncol, (2001). 19, 4014–4022.

    Article  CAS  Google Scholar 

  3. Kantarjian, HM, O’Brien, S, Smith, TL, Cortes, J, Giles, FJ, Beran, M, Pierce, S, Huh, Y, Andreeff, M, Koller, C, Ha, CS, Keating, MJ, Murphy, S & Freireich, EJ Results of treatment with hyper-CVAD, a dose-intensive regimen, in adult acute lymphocytic leukemia. J Clin Oncol, (2000). 18, 547–561.

    Article  CAS  Google Scholar 

  4. Zhang, W, Ohnishi, K, Shigeno, K, Fujisawa, S, Naito, K, Nakamura, S, Takeshita, K, Takeshita, A & Ohno, R The induction of apoptosis and cell cycle arrest by arsenic trioxide in lymphoid neoplasms. Leukemia, (1998). 12, 1383–1391.

    Article  CAS  Google Scholar 

  5. Zhu, XH, Shen, YL, Jing, YK, Cai, X, Jia, PM, Huang, Y, Tang, W, Shi, GY, Sun, YP, Dai, J, Wang, ZY, Chen, SJ, Zhang, TD, Waxman, S, Chen, Z & Chen, GQ Apoptosis and growth inhibition in malignant lymphocytes after treatment with arsenic trioxide at clinically achievable concentrations. J Natl Cancer Inst, (1999). 91, 772–778.

    Article  CAS  Google Scholar 

  6. Macpherson, N, Lesack, D, Klasa, R, Horsman, D, Connors, JM, Barnett, M & Gascoyne, RD Small noncleaved, non-Burkitt's (Burkitt-like) lymphoma: cytogenetics predict outcome and reflect clinical presentation. J Clin Oncol, (1999). 17, 1558–1567.

    Article  CAS  Google Scholar 

  7. van Besien, K, Rodriguez, A, Tomany, S, Younes, A, Donato, M, Sarris, A, Giralt, S, Mehra, R, Andersson, B, Gajewski, J, Champlin, R & Cabanillas, F Phase II study of a high-dose ifosfamide-based chemotherapy regimen with growth factor rescue in recurrent aggressive NHL. High response rates and limited toxicity, but limited impact on long-term survival. Bone Marrow Transplant, (2001). 27, 397–404.

    Article  CAS  Google Scholar 

  8. Li, YS, Zhang, TD & Li, CW Traditional Chinese and western medicine in the treatment of 27 patients with malignant lymphoma. Zhonghua zhong liu za zhi (Chinese Journal of Oncology), (1988). 10, 61–62.

    CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. The University of Illinois, Chicago, IL, USA

    F Ravandi & K van Besien

Authors
  1. F Ravandi
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. K van Besien
    View author publications

    You can also search for this author in PubMed Google Scholar

Rights and permissions

Reprints and permissions

About this article

Cite this article

Ravandi, F., van Besien, K. Clinical activity of arsenic trioxide in Burkitt-like lymphoma. Leukemia 17, 271–272 (2003). https://doi.org/10.1038/sj.leu.2402735

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1038/sj.leu.2402735

  • Springer Nature Limited

This article is cited by

Search

Navigation